2017
Abuse-Deterrent Opioid Formulations — Putting the Potential Benefits into Perspective
Becker WC, Fiellin DA. Abuse-Deterrent Opioid Formulations — Putting the Potential Benefits into Perspective. New England Journal Of Medicine 2017, 376: 2103-2105. PMID: 28564568, DOI: 10.1056/nejmp1701553.Peer-Reviewed Educational MaterialsEvaluation of an Integrated, Multidisciplinary Program to Address Unsafe Use of Opioids Prescribed for Pain
Becker WC, Edmond SN, Cervone DJ, Manhapra A, Sellinger JJ, Moore BA, Edens EL. Evaluation of an Integrated, Multidisciplinary Program to Address Unsafe Use of Opioids Prescribed for Pain. Pain Medicine 2017, 19: 1419-1424. PMID: 28371816, DOI: 10.1093/pm/pnx041.Peer-Reviewed Original ResearchConceptsPreliminary efficacyUnsafe useSubstance abuse/dependenceMultidisciplinary care teamSubstance use disorder diagnosisPrimary care physiciansAdvanced practice nursesUrine drug testingLength of treatmentStructured clinical assessmentNurse case managersAbuse/dependenceHealth system levelHigh-complexity patientsElectronic progress notesOpioid prescribedOpioid receiptCare physiciansPractice nursesPrimary careCare coordinationCare teamClinical assessmentCare modelClinic processes
2014
Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder
Becker WC, Ganoczy D, Fiellin DA, Bohnert AS. Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder. Journal Of Substance Use And Addiction Treatment 2014, 48: 128-131. PMID: 25312475, DOI: 10.1016/j.jsat.2014.09.007.Peer-Reviewed Original ResearchConceptsOpioid use disorderNumerical rating scoreBUP/NXPain intensityUse disordersPrimary outcomeBuprenorphine/naloxone doseDecreased pain intensityFull agonist opioidsImproved pain intensityBuprenorphine/naloxoneSubset of patientsSubstance use comorbiditiesChronic pain diagnosesPartial agonist propertiesEligible patientsNX treatmentAgonist opioidsPain levelsNaloxone doseComorbid painMultivariable analysisMaintenance treatmentMean ageClinical correlates
2012
Federal plan for prescriber education on opioids misses opportunities.
Becker WC, Fiellin DA. Federal plan for prescriber education on opioids misses opportunities. Annals Of Internal Medicine 2012, 157: 205-6. PMID: 22868838, DOI: 10.7326/0003-4819-157-3-201208070-00448.Peer-Reviewed Educational Materials
2011
Nonmedical Use of Opioid Analgesics Obtained Directly From Physicians: Prevalence and Correlates
Becker WC, Tobin DG, Fiellin DA. Nonmedical Use of Opioid Analgesics Obtained Directly From Physicians: Prevalence and Correlates. JAMA Internal Medicine 2011, 171: 1034-1036. PMID: 21670373, DOI: 10.1001/archinternmed.2011.217.Peer-Reviewed Original Research
2010
Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.
Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Annals Of Internal Medicine 2010, 152: 712-20. PMID: 20513829, DOI: 10.7326/0003-4819-152-11-201006010-00004.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidChronic DiseaseDrug MonitoringHumansOpioid-Related DisordersPainUrinalysisConceptsUrine drug testingOpioid treatment agreementsPrimary care settingOpioid misuseTreatment agreementsChronic painDrug testingEligible studiesCare settingsAberrant drug-related behaviorsDrug abuseMental Health Services AdministrationOpioid misuse outcomesChronic noncancer painCochrane Central RegisterProportion of patientsPrimary care studyControlled Clinical TrialsHealth Services AdministrationDrug-related behaviorsCombination of interventionsNoncancer painDiversity of interventionsOpioid medicationsCentral Register